HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Held Off By Latisse, Lash Allure Touts Results In A Blink At Low Price Point

This article was originally published in The Rose Sheet

Executive Summary

A late entrant to the crowding eyelash enhancement market, Beauty Biosciences seeks to differentiate Lash Allure MD on the basis of price and speed of results

You may also be interested in...



FDA’s Warning To Lash-Growth Firm Shows Risks In Third-Party Claims

An April 18 FDA warning letter to Lifetech Resources LLC demonstrates that cosmetics firms will be held accountable when their websites feature third-party claims and testimonials that cross into drug marketing territory.

FDA’s Warning To Lash-Growth Firm Shows Risks In Third-Party Claims

An April 18 FDA warning letter to Lifetech Resources LLC demonstrates that cosmetics firms will be held accountable when their websites feature third-party claims and testimonials that cross into drug marketing territory.

Markwins' Wet N Wild To Offer Value-Priced Lash-Growth Products In 2011

Markwins' wet n wild brand plans to make a splash in the typically pricey lash-growth market with the introduction of a $6.99 serum at mass retailers in January 2011

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

RS016516

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel